$NewAmsterdam Pharma (NAMS.US)$ 10% Shareholder ForGrowth NAP B.V. sold 191.76K shares of common stock on Dec 12, 13, 2024 at an average price of $25.3433 for a total value of $4.86 million.
This transaction involves other related parties: Forbion Capital Fund IV Cooperatief U.A., Forbion IV Management B.V., Forbion Growth Opportunities Fund I Cooperatief U.A. and Forbion Growth Management B.V..
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.
